Page 231 - Kolte Patil AR 2019-20

Notes forming part of the Consolidated Financial Statements

The exercise period shall commence from the date of vesting of option and expire not later than 12 (Twelve) months from the vesting date
of option. Options not exercised during any particular exercise period, can be carried forward to the subsequent exercise period(s), provided
however that all the Options, have to be exercised within a period of 2 years from the date of the vesting period in respect of the final lot,
after which any unexercised Options will lapse.
The vesting period of the above mentioned ESOS Schemes is as follows –

i. Details of activity of the ESOP schemes
Movement for the year ended March 31, 2020 and year ended March 31, 2019:

Outstanding
Granted Forfeited Lapsed Exercised Outstanding Exercisable
ESOP at the
Particulars Year ended during during during during at the end of at the end
Scheme beginning of
the year the year the year the year the year of the year
the year
Number of March 31, 2020 379,000 - - - - 379,000 379,000
options
Weighted average March 31, 2020 142 - - - - 142 142
exercise price
Number of March 31, 2019 26,500 379,000 - 10,000 16,500 379,000 379,000
ESOS 2014 options
Weighted average March 31, 2019 142 141 - 142 142 141 141
exercise price

ii. Information in respect of options outstanding:

ESOP Scheme Exercise price As at March 31, 2020 As at March 31, 2019
Weighted average Weighted average
Number of Options remaining life Number of Options remaining life
Outstanding Outstanding
(in Years) (in Years)
141 - - - -
ESOS 2014
145 379,000 0 - 4 379,000 0 - 4

iii. The employee stock option cost for the Employee Stock Option Scheme 2014 has been computed by reference to the fair value of share
options granted and amortized over each vesting period. For the year ended March 31, 2019 the Company has accounted for employee stock
Option cost (equity settled) amounting to ` 196 Lakhs (March 31, 2019: ` 168 Lakhs).
iv. The fair value of each option is estimated on the date of grant based on the following assumptions (on weighted average basis):

For the year ended For the year ended
Particulars
March 31, 2020 March 31, 2019
Weighted average share price 265 265
Exercise price 145 145
Expected Volatility (%) 58.77% 58.77%
1 year from the date 1 year from the date
Expected life
of vesting of vesting
Expected dividend (%) 2% 2%
Risk free interest rate (%) 8.20% 8.20%

Annual Report 2019-20 | 229